180 related articles for article (PubMed ID: 23512667)
1. Muscle ring finger 1 and muscle ring finger 2 are necessary but functionally redundant during developmental cardiac growth and regulate E2F1-mediated gene expression in vivo.
Willis MS; Wadosky KM; Rodríguez JE; Schisler JC; Lockyer P; Hilliard EG; Glass DJ; Patterson C
Cell Biochem Funct; 2014 Jan; 32(1):39-50. PubMed ID: 23512667
[TBL] [Abstract][Full Text] [Related]
2. Cardiac muscle ring finger-1 increases susceptibility to heart failure in vivo.
Willis MS; Schisler JC; Li L; Rodríguez JE; Hilliard EG; Charles PC; Patterson C
Circ Res; 2009 Jul; 105(1):80-8. PubMed ID: 19498199
[TBL] [Abstract][Full Text] [Related]
3. Fenofibrate unexpectedly induces cardiac hypertrophy in mice lacking MuRF1.
Parry TL; Desai G; Schisler JC; Li L; Quintana MT; Stanley N; Lockyer P; Patterson C; Willis MS
Cardiovasc Pathol; 2016; 25(2):127-140. PubMed ID: 26764147
[TBL] [Abstract][Full Text] [Related]
4. Muscle ring finger 1, but not muscle ring finger 2, regulates cardiac hypertrophy in vivo.
Willis MS; Ike C; Li L; Wang DZ; Glass DJ; Patterson C
Circ Res; 2007 Mar; 100(4):456-9. PubMed ID: 17272810
[TBL] [Abstract][Full Text] [Related]
5. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2.
Witt CC; Witt SH; Lerche S; Labeit D; Back W; Labeit S
EMBO J; 2008 Jan; 27(2):350-60. PubMed ID: 18157088
[TBL] [Abstract][Full Text] [Related]
6. Rare variants in genes encoding MuRF1 and MuRF2 are modifiers of hypertrophic cardiomyopathy.
Su M; Wang J; Kang L; Wang Y; Zou Y; Feng X; Wang D; Ahmad F; Zhou X; Hui R; Song L
Int J Mol Sci; 2014 May; 15(6):9302-13. PubMed ID: 24865491
[TBL] [Abstract][Full Text] [Related]
7. Muscle-specific RING finger 1 negatively regulates pathological cardiac hypertrophy through downregulation of calcineurin A.
Maejima Y; Usui S; Zhai P; Takamura M; Kaneko S; Zablocki D; Yokota M; Isobe M; Sadoshima J
Circ Heart Fail; 2014 May; 7(3):479-90. PubMed ID: 24526353
[TBL] [Abstract][Full Text] [Related]
8. Expression of MuRF1 or MuRF2 is essential for the induction of skeletal muscle atrophy and dysfunction in a murine pulmonary hypertension model.
Nguyen T; Bowen TS; Augstein A; Schauer A; Gasch A; Linke A; Labeit S; Adams V
Skelet Muscle; 2020 Apr; 10(1):12. PubMed ID: 32340625
[TBL] [Abstract][Full Text] [Related]
9. MuRF1 is a muscle fiber-type II associated factor and together with MuRF2 regulates type-II fiber trophicity and maintenance.
Moriscot AS; Baptista IL; Bogomolovas J; Witt C; Hirner S; Granzier H; Labeit S
J Struct Biol; 2010 May; 170(2):344-53. PubMed ID: 20149877
[TBL] [Abstract][Full Text] [Related]
10. Muscle-specific regulation of right ventricular transcriptional responses to chronic hypoxia-induced hypertrophy by the muscle ring finger-1 (MuRF1) ubiquitin ligase in mice.
Oakley RH; Campen MJ; Paffett ML; Chen X; Wang Z; Parry TL; Hillhouse C; Cidlowski JA; Willis MS
BMC Med Genet; 2018 Sep; 19(1):175. PubMed ID: 30241514
[TBL] [Abstract][Full Text] [Related]
11. Non-targeted metabolomics analysis of cardiac Muscle Ring Finger-1 (MuRF1), MuRF2, and MuRF3 in vivo reveals novel and redundant metabolic changes.
Banerjee R; He J; Spaniel C; Quintana MT; Wang Z; Bain J; Newgard CB; Muehlbauer MJ; Willis MS
Metabolomics; 2015 Apr; 11(2):312-322. PubMed ID: 28325996
[TBL] [Abstract][Full Text] [Related]
12. The Role of Muscle Ring Finger-1 (MuRF1), MuRF2, MuRF3, and Atrogin-1 on Bone Microarchitecture In Vivo.
Suryadevara V; Krehbial CJ; Halsey D; Willis MS
Cell Biochem Biophys; 2022 Jun; 80(2):415-426. PubMed ID: 35191000
[TBL] [Abstract][Full Text] [Related]
13. Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.
Wadosky KM; Rodríguez JE; Hite RL; Min JN; Walton BL; Willis MS
Am J Physiol Endocrinol Metab; 2014 Apr; 306(7):E723-39. PubMed ID: 24425758
[TBL] [Abstract][Full Text] [Related]
14. AMP-activated protein kinase regulates E3 ligases in rodent heart.
Baskin KK; Taegtmeyer H
Circ Res; 2011 Oct; 109(10):1153-61. PubMed ID: 21921267
[TBL] [Abstract][Full Text] [Related]
15. MuRF1 mono-ubiquitinates TRα to inhibit T3-induced cardiac hypertrophy in vivo.
Wadosky KM; Berthiaume JM; Tang W; Zungu M; Portman MA; Gerdes AM; Willis MS
J Mol Endocrinol; 2016 Apr; 56(3):273-90. PubMed ID: 26862156
[TBL] [Abstract][Full Text] [Related]
16. Cardiac proteasome activity in muscle ring finger-1 null mice at rest and following synthetic glucocorticoid treatment.
Hwee DT; Gomes AV; Bodine SC
Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E967-77. PubMed ID: 21828340
[TBL] [Abstract][Full Text] [Related]
17. Rise above: muscle ring-finger-1 (MURF1) regulation of cardiomyocyte size and energy metabolism.
Patterson C; Willis MS; Portbury A
Trans Am Clin Climatol Assoc; 2011; 122():70-81. PubMed ID: 21686210
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Glucose Metabolism by MuRF1 and Treatment of Myopathy in Diabetic Mice with Small Molecules Targeting MuRF1.
Labeit S; Hirner S; Bogomolovas J; Cruz A; Myrzabekova M; Moriscot A; Bowen TS; Adams V
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672385
[TBL] [Abstract][Full Text] [Related]
19. MuRF2 regulates PPARγ1 activity to protect against diabetic cardiomyopathy and enhance weight gain induced by a high fat diet.
He J; Quintana MT; Sullivan J; L Parry T; J Grevengoed T; Schisler JC; Hill JA; Yates CC; Mapanga RF; Essop MF; Stansfield WE; Bain JR; Newgard CB; Muehlbauer MJ; Han Y; Clarke BA; Willis MS
Cardiovasc Diabetol; 2015 Aug; 14():97. PubMed ID: 26242235
[TBL] [Abstract][Full Text] [Related]
20. Suppression of atrogin-1 and MuRF1 prevents dexamethasone-induced atrophy of cultured myotubes.
Castillero E; Alamdari N; Lecker SH; Hasselgren PO
Metabolism; 2013 Oct; 62(10):1495-502. PubMed ID: 23866982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
